Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 04:10 PM EDT

Passage Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 3.21M n/a n/a n/a 5.91M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
200K 201K 719K 800K 800K 806K 807K 1M 978K 978K 946K 929K 921K 883K 669K 460K 203K 211K
Gross Profit
-200K -201K 1.61M -800K -800K -806K 5.11M -1M -978K -978K -946K -929K -921K -883K -669K -460K -203K -211K
Operating Income
-10.33M -16.46M -14.27M -20.7M -17.38M -18.05M -18.45M -28.67M -25.39M -35.88M -28.24M -27.53M -39.81M -42.81M -51.16M -47.1M -48.53M -38.93M
Interest Income
n/a 700K 800K 1.1M 1.2M 1.3M 1.5M n/a 1.5K n/a 1.17M 825K 270K 1K 6K 186K 99K 52K
Pretax Income
-9.38M -15.4M -12.72M -19.34M -15.99M -16.71M -16.76M -27.11M -23.86M -34.34M -27.07M -26.7M -39.54M -42.81M -51.15M -46.91M -48.44M -38.88M
Net Income
-9.38M -15.4M -12.72M -19.34M -15.99M -16.71M -16.76M -27.11M -23.86M -32.79M -25.9M -26.7M -39.27M -42.81M -51.15M -46.91M -48.44M -38.88M
Selling & General & Admin
4.52M 6.08M 4.71M 7.25M 6.51M 6.51M 5.48M 8.18M 8.06M 19.05M 10.59M 10.66M 12.99M 15.1M 17.19M 14.98M 15.42M 12.46M
Research & Development
5.81M 7.74M 9.56M 8.66M 10.43M 11.54M 12.16M 15.1M 17.32M 16.84M 17.66M 15.36M 26.82M 26.21M 32.97M 26.62M 33.11M 24.97M
Other Expenses
n/a -201K 806K 4.79M 438K n/a 807K 5.39M 1.53M 1.54M n/a 825K 270K 1K n/a n/a n/a n/a
Operating Expenses
10.33M 13.62M 15.08M 20.7M 17.38M 18.05M 18.45M 28.67M 25.39M 35.88M 28.24M 26.03M 39.81M 41.31M 50.16M 41.6M 48.53M 37.43M
Interest Expense
n/a n/a n/a n/a n/a n/a 1.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -807K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.33M 13.82M 14.27M 20.7M 17.38M 18.05M 18.45M 28.67M 25.39M 35.88M 28.24M 27.53M 39.81M 41.31M 50.16M 41.6M 48.53M 37.43M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.54M -1.17M n/a -270K -1K -6K -186K -99K n/a
Shares Outstanding (Basic)
3.17M 3.11M 3.1M 3.09M 3.08M 2.81M 2.75M 2.74M 2.73M 2.73M 2.73M 2.72M 2.72M 2.71M 2.7M 2.7M 2.69M 2.57M
Shares Outstanding (Diluted)
3.17M 3.11M 3.1M 3.09M 3.08M 2.81M 2.75M 2.74M 2.73M 2.73M 2.73M 2.72M 2.72M 2.71M 2.7M 2.7M 2.69M 2.57M
EPS (Basic)
-2.96 -4.96 -4.1 -6.26 -5.18 -5.94 -6.1 -9.9 -8.8 -12 -9.4 -9.8 -14.4 -15.8 -19 -17.4 -18 -15.2
EPS (Diluted)
-2.96 -4.96 -4.1 -6.26 -5.18 -5.94 -6.1 -9.9 -8.8 -12 -9.4 -9.8 -14.4 -15.8 -19 -17.4 -18 -15.2
EBITDA
-10.33M -13.62M -13.55M -15.15M -16.14M -17.24M -17.64M -22.32M -24.41M -34.91M -27.3M -25.1M -38.89M -40.43M -49.49M -41.14M -48.33M -37.22M
EBIT
-9.38M -13.82M -14.27M -15.91M -16.94M -18.05M -18.45M -27.11M -25.39M -34.34M -27.07M -26.03M -39.81M -41.31M -50.16M -41.6M -48.53M -37.43M
Depreciation & Amortization
200K 201K 719K 759K 797K 806K 807K 958K 978K 978K 946K 929K 921K 883K 669K 460K 203K 211K